Downregulation of p300 alleviates LPS-induced inflammatory injuries through regulation of RhoA/ROCK/NF- κB pathways in A549 cells

In conclusion, p300 might be involved in progression of cell inflammatory response and could serve as a novel therapeutic target for clinical treatment of infantile pneumonia.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research